Product
CHF6563
1 clinical trial
1 indication
Indication
Neonatal Opioid Withdrawal SyndromeClinical trial
A Phase II, Multicenter, Double Blind, Double Dummy, Randomized, 2 Arms Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CHF6563 in Babies With Neonatal Opioid Withdrawal SyndromeStatus: Terminated, Estimated PCD: 2021-12-13